Publikationen

  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
Giunta C, Baumann M, Fauth C, Lindert U, Abdalla EM, Brady AF, Collins J, Dastgir J, Donkervoort S, Ghali N, Johnson DS, Kariminejad A, Koch J, Kraenzlin M, Lahiri N, Lozic B, Manzur AY, Morton JEV, Pilch J, Pollitt RC, Schreiber G, Shannon NL, Sobey G, Vandersteen A, van Dijk FS, Witsch-Baumgartner M, Zschocke J, Pope FM, Bönnemann CG, Rohrbach M.
A cohort of 17 patients with kyphoscoliotic Ehlers-Danlos syndrome caused by biallelic mutations in FKBP14: expansion of the clinical and mutational spectrum and description of the natural history.
Genet Med. 2017 Jun 15. Epub ahead of print]

Gotthardt F., Huber C., Thierfelder C., Grize L., Kraenzlin M., Scheidegger C., Meier C.
Determinants of bone mineral density in men with opioid dependence
J Bone Miner Metab 2017, 35: 99-107

J. A. Kanis, C. Cooper, R. Rizzoli5, B. Abrahamsen, N. M. Al-Daghri, M. L. Brandi, J. Cannata-Andia, B. Cortet, H. P. Dimai, S. Ferrar, P. Hadji, N. C. Harvey, M. Kraenzlin, A. Kurth, E. McCloskey, S. Minisola, T. Thomas, J.-Y. Reginster
Identification and management of patients at increased risk of osteoporotic fracture: Outcomes of an ESCEO expert consensus meeting
Osteoporos Int. 2017 in print

Kraenzlin M.E., Jakob F.
Schmerzen bei Erkrankungen des Knochens.
In: E. Battegay Ed. Siegenthaler's Differentialdiagnose innerer Kranheiten. 21. Auflage 2017;in print

Kraenzlin M., Meier C.
Kalziumstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., in print 2017

Meier C., Uebelhart B., Aubry-Rozier B., Birkhäuser M., Bischoff-Ferrari H., Frey D., Kressig R.W., Lamy O., Lippuner K., Stute P., Suhm N., Ferrari S.
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the Swiss Association against Osteoporosis (SVGO/ASCO)
Swiss Med Wkly 2017, epub

Meier C., Jockers F., Kraenzlin M.
Systemische Mastocytose: Ein 56-jähriger Mann mit einer fortgeschrittenen Osteoporose
In: 50 Fälle Osteologie. Ed: A. Roth 2017, in print

Meier C., Kraenzlin M.
Parathormonstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., in print 2017

Seelig E, Meyer S, Timper K, Nigro N, Bally M, Pernicova I, Schuetz P, Muller
B, Korbonits M, Christ-Crain M. Metformin prevents metabolic side effects during systemic glucocorticod treatment.
Europ J Endocrinol 2017, 176: 413-419

Struja T, Kaeslin M, Boesiger F, Jutzi R, Imahorn N, Kutz A, Bernasconi L, Mundwiler E, Mueller B, Christ-Crain M, Meienberg F, Ebrahimi F, Henzen C, Fischli S, Kraenzlin M, Meier C, Schuetz P.
External validation of the GREAT score to predict relapse risk in Graves' disease Results from a multicenter, retrospective study with 741 patients.
Eur J Endocrinol. 2017 Jan 18. Epub

Struja T., Kutz A., Fischli S., Meier C., Mueller B., Recher M., Schuetz P.
Personalized, immune-modulating treatments for Graves‘ disease: Fact or fiction?
Swiss Med Wkly 2017, epub

Bally MR, Blaser Yildirim PZ, Bounoure L, Gloy VL, Mueller B, Briel M, Schuetz P.
Nutritional Support and Outcomes in Malnourished Medical Inpatients: A Systematic Review and Meta-analysis.
JAMA Intern Med. 2016;176(1):43-53.

Bally M.
Polyglanduläres Autoimmunsyndrom
Rheuma Schweiz 2016; 4: 8-14

Egger A. , Kraenzlin M., Meier C.
Osteoporose und Typ 2 Diabetes
Diabetologe 2016; 12: 254-260

Egger A., Meier C
Diabetes mellitus Typ 2 und Knochen: Was es zu beachten gibt
Rheuma Schweiz 2016; 4: 26-30

Egger A., Meier C.
Effects of incretin-based therapies and SGLT2 inhibitors on skeletal health
Current Osteoporosis Reports 2016; in print

Gotthardt F., HuberC., Thierfelder C., Grize L., Kraenzlin M., Scheidegger C., Meier C.
Determinants of bone mineral density in men with opioid dependence
J Bone Miner Metab 2016; in print

Gröger F., Cronenberg S., Hirschmann A., Jakob M., Rikli D., Meier C., Bless N., Studer P., Suhm N.
“Atypische Femurfrakturen” – Zwei Denkanstösse anhand von drei Fallstudien
Osteologie 2016; 25: 37

Hepprich M., Meier C.
Schilddrüsenerkrankungen.
In: Der Risikopatient in der zahnärztlichen Praxis. Hrsg. J.T. Lambrecht, M. von Planta 2016; in print

Kraenzlin M., Meier C.
Kalziumstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., 2016; in print

Kraenzlin M., Meier C.
Osteoporose
In: Der Risikopatient in der zahnärztlichen Praxis. Hrsg. J.T. Lambrecht, M. von Planta 2016; in print

Kraenzlin M., Meier C.
Evaluation des Frakturrisikos mittels dem „ WHO Fracture Risk Assessment Tool“ FRAX©
Der informierte Arzt (2016), 11, 15-19

Meier C., Schwartz A., Egger A., Lecka-Cerna B.
Effects of diabetes drugs on the skeleton
Bone 2016; 82: 93-100

Meier C., Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter
In: Käftig altern – Die Bedeutung der Kraft im demographischen Wandel.Ed: Menzi et al. 2016; in print

Meier C., Kraenzlin M.
Parathormonstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., 2016; in print

Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum CA, Nickel CH, Bingisser R, Bock A, Huber A, Müller B, Christ-Crain M.
Evaluation of copeptin and commonly used laboratory parameters for the differential diagnosis of profound hyponatraemia in hospitalized patients: 'The Co-MED Study'.
Clin Endocrinol (Oxf). 2016 Sep 22. Epub

Oranges C., Meier C., Schaefer D.
Surgical Timing and the Menstrual Cycle Affect Wound Healing in Young Breast Reduction Patients. Letter to the Editor Plastic and Reconstructive
Surgery 2016; in print

Schuetz P, Meier MA, Bally MR, Gomes F, Mueller B.
Industry sponsorship and outcomes of nutrition studies: Is there an association when looking at the trial level?
Clin Nutr. 2016 Dec 26. Epub

Spoendlin C., Meier C., Jick S.S., Meier C.R.
Achilles or biceps tendon rupture in women and men with type 2 diabetes: A population-based case-control study
J Diabetes Complications 2016; 30: 903-909.

Spoendlin C., Meier C., Jick S.S., Meier C.R.
Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study
Pharmacoepidemiol Drug Saf (2016), 25: 1116-1123

Spoendlin J., Bradley Layton J., Mundkur M., Meier C., Jick S.S., Meier C.R.
The risk of Achilles or biceps tendon rupture in new statin users: A propensity score-matched sequential cohort study
Drug Safety (2016), 39: 1229-1237; in print

Suhm N., Meier C., Kraenzlin M., Kungler E., Savic B., Mueller S., Jakob M., Rikli D.
FLS – Drei Buchstaben verändern die sekundäre Frakturprävention
Unfallchirurg 2016; 119: 12-17

Theiler R., Freystaetter G., Platz A., Meier C., Mellinghoff H-U.
Capture the fracture by SMS
Osteologie (2016), 4: 283-286

Trombetti A., Christ E.R., Henzen C., Gold G., Brändle M., Herrmann F.R., Torriani C., Triponez F., Bilezikian J.P., Kraenzlin M., Rizzoli R., Meier C.
Clinical presentation and management of patients with primary hyperparathyroidism belonging to the Swiss Primary Hyperparathyroidism Cohort: A focus on neurobehavioral and cognitive symptoms
J Endocrinol Invest 2016; 39:567-576

Whiting SJ, Kohrt WM, Warren MP, Kraenzlin MI, Bonjour JP.
Food fortification for bone health in adulthood: a scoping review.
Eur J Clin Nutr. 2016;70(10):1099-1105

Winzeler B, Jeanloz N, Nigro N, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum C, Bock A, Huber A, Mueller B, Christ-Crain M.
Long-term outcome of profound hyponatremia: a prospective 12 months follow-up study.
Eur J Endocrinol. 2016 (6):499-507.

Winzeler B, Lengsfeld S, Nigro N, Suter-Widmer I, Schütz P, Arici B, Bally M, Blum C, Bock A, Huber A, Müller B, Christ-Crain M.
Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriatea ntidiuresis.
J Intern Med. 2016;280(6):609-617


Abdalla EM, Rohrbach M, Bürer C, Kraenzlin M, El-Tayeby H, Elbelbesy MF, Nabil A, Giunta C.
Kyphoscoliotic type of Ehlers-Danlos Syndrome (EDS VIA) in six Egyptian patients presenting with a homogeneous clinical phenotype.
Eur J Pediatr. 2015;174:105-12

Bally M., Kraenzlin M., Meier C.
Osteoporose, Update 2015
Der informierte Arzt 2015, 45-49

Bally M., Kraenzlin M., Meier C.
Osteoporose, Update 2015
info@gynäkologie 2015: 20-23

Felder S, Lechtenboehmer C, Bally M, Fehr R, Deiss M, Faessler L, Kutz A, Steiner D, Rast AC, Laukemann S, Kulkarni P, Stanga Z, Haubitz S, Huber A, Mueller B, Schuetz P.
Association of nutritional risk and adverse medical outcomes across different medical inpatient populations.
Nutrition 2015;31(11-12):1385-93

Gotthardt F., HuberC., Thierfelder C., Grize L., Kraenzlin M., Scheidegger C., Meier C.
Determinants of bone mineral density in men with opioid dependence
J Bone Miner Metab, in print

Kraenzlin M.
Osteoporose Update 2015: dignostische und therapeutische Intervention
Swiss Medical Forum 2015;15(37):808-813

Kraenzlin M, Meier C.
Sinn und Unsinn der Vitamin-D Bestimmung : analytische Bestimmung des Vitamin D, optimaler Status und Supplementation
Osteologie 2015;in print

Kraenzlin M., Meier C.
Kalziumstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., in print (2015)

Lindert U, Kraenzlin M, Campos-Xavier AB, Baumgartner MR, Bonafé L, Giunta C, Rohrbach M.
Urinary pyridinoline cross-links as biomarkers of osteogenesis imperfecta.
Orphanet J Rare Dis. 2015 Aug 27;10:104

Meier C, Schwartz AV, Egger A, Lecka-Czernik B.
Effects of diabetes drugs on the skeleton.
Bone. 2015 Apr 23. pii: S8756-3282(15)00139-8

Meier C.
Benefits and place of calcimimetics in the management of primary hyperparathyroidism.
Ann Endocrinol (Paris). 2015;76:163-4

Meier C., Kraenzlin M.
Parathormonstoffwechsel.
In: Lehrbuch Osteologie. Hrsg. Lange U. and Kurth A., in print (2015)

Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum C, Bingisser R, Bock A, Huber A, Müller B, Nickel CH, Christ-Crain M.
Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study.
J Am Geriatr Soc. 2015 Mar;63(3):470-5.

Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum CA, Nickel CH, Bingisser R, Bock A, Rentsch Savoca K, Huber A, Müller B, Christ-Crain M.
Mid-regional pro-atrial natriuretic peptide and the assessment of volaemic status and differential diagnosis of profound hyponatraemia.
J Intern Med. 2015 Jul;278(1):29-37.

Spoendlin J, Meier C, Jick SS, Meier CR.
Oral and inhaled glucocorticoid use and risk of Achilles or biceps tendon rupture: a population-based case-control study.
Ann Med. 2015;47:492-8

Nigro N, Winzeler B, Suter-Widmer I, Schuetz P, Arici B, Bally M, Blum C, Bingisser R, Bock A, Huber A, Müller B, Nickel CH, Christ-Crain M.
Symptoms and characteristics of individuals with profound hyponatremia: a prospective multicenter observational study.
J Am Geriatr Soc 2015;63(3):470-5

Trombetti A., Christ E.R., Henzen C., Gold G., Brändle M., Herrmann F.R., Torriani C., Triponez F., Bilezikian J.P., Kraenzlin M., Rizzoli R., Meier C.
Clinical presentation and management of patients with primary hyperparathyroidism belonging to the Swiss Primary Hyperparathyroidism Cohort: A special focus on neurobehavioral and cognitive symptoms
J Endocrinol Invest, in print

Winzeler B., Christ-Crain M., Staub J.J., Müller B., Meier C.
Subclinical Hypothyroidism
Reference Module in Biomedical Sciences, Elsevier (2015)

Winzeler B, Zweifel C, Nigro N, Arici B, Bally M, Schuetz P, Blum CA, Kelly C, Berkmann S, Huber A, Gentili F, Zadeh G, Landolt H, Mariani L, Müller B, Christ-Crain M.
Postoperative Copeptin Concentration Predicts Diabetes Insipidus After Pituitary Surgery.
J Clin Endocrinol Metab 2015;100(6):2275-82


Abdalla EM, Rohrbach M, Bürer C, Kraenzlin M, El-Tayeby H, Elbelbesy MF, Nabil A, Giunta C.
Kyphoscoliotic type of Ehlers-Danlos Syndrome (EDS VIA) in six Egyptian patients presenting with a homogeneous clinical phenotype.
Eur J Pediatr. 2014 Oct 3. [Epub ahead of print]

Bonjour JP, Kohrt W, Levasseur R, Warren M, Whiting S, Kraenzlin M.
Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.
Nutr Res Rev. 2014 Nov 14:1-16. [Epub ahead of print]

Jockers S., Kraenzlin M., Kraenzlin C., Meier C.
Systemische Mastozytose: Eine seltene Ursache einer fortgeschrittenen Osteoporose beim Mann
Osteologie 2014, 23: 56-60

Kraenzlin M., Meier C.
Sexualhormone und Knochen
Therapeutische Umschau 2014, 71: 209-219

Kreutle V., BlumC., Meier C., Mueller B., Schuetz P., Borm K.
Bisphosphonate-induced hypocalcemia: Report of six cases and review of the literature
Swiss Med Wkly 2014, 144:w13979

Meier C., Kraenzlin C., Friedrich N.F., Wischer T., Grize L., Meier C.R., Kraenzlin M.E.
Effect of ibandronate for the treatment of osteonecrosis of the knee: A randomized, double-blind, placebo-controlled trial
Osteoporos Int 2014, 25: 359-366

Meier C., Lamy O., Krieg M.A, Mellinghoff H.U., Felder M., Ferrari S., Rizzoli R.
The role of teriparatide in sequential and combination therapy of osteoporosis.
Swiss Med Wkly 2014, 144: w13952

Meier C.
Osteoporose, Wenn die Knochen brüchig werden
my Health Initiative 2014, Gesundheitsfibel für die Frau 2014, 1: 34

Nigro N., Christ-Crain M., Meier C.
Hormonersatzbehandlung in der Andropause: Nutzen und Gefahren
Therapeutische Umschau 2014, 71: 229-237

Stute P., Birkhäuser M., von Wolff M., Meier C.
Gynecologists’ awareness of bone health care in Switzerland
Swiss Med Wkly 2014, 144: w13931

Schreiner S., Savic B., Cronenberg S., Meier C., Kraenzlin M., Jakob M., Suhm N.
Der „Versorgungsgap“ nach osteoporoseassoziierter Fraktur – nur ein Artefakt von diagnosecodebasierten Abklärungsalgorithmen?
Orthopäde 2014, in print

Theiler R., Meier C., Lippuner K.
FRAX-Tool zur Berechnung des absoluten Frakturrisikos bei Osteoporose. Replik
Swiss Med Forum 2014, 14: 137











Bonafe L.,Giunta C., Hasler C., Janner M., Kränzlin M., Link B., Meier C., Ramseier L., Rohrbach M., Unger S.
Osteogenesis imperfecta (OI): Klinik, Diagnose und Management vom Kindesalter bis ins Erwachsenenalter
Schweiz Med Forum 2013;13:925–931

Bonjour JP, Benoit V, Payen F and Kraenzlin M.
Fortification of yogurts with calcium and vitamin D enhances the inhibition of bone resorption markers: a double-blind randomized controlled trial in institutionalized elderly women.
J Clin Endocrinol Metab. 2013;98:2915–2921

Bonjour JP, Kraenzlin M, Levasseur R, Warren M, Whiting S.
Dairy in adulthood: from foods to nutrient interactions on bone and skeletal muscle health.
J Am Coll Nutr. 2013;32:251-63

Hadji P., Bock O., Resch H., Kraenzlin M., Wang A., Steinle T., Eisen C.
Reduktion des Frakturrisikos unter Denosumab bei postmenopausalen Frauen in Abhängigkeit der Behandlungsbedürftigkeit nach DVO-Leitlinie 2009
Osteologie 2013;1:39-45

Henzen C., Kraenzlin M., Meier C.
Endokrinologische Laboruntersuchungen – Wo liegen die Probleme?
Therapeutische Umschau 2013;70:481-489

Kraenzlin M.E.
Evaluation des absoluten Frakturrisikos: "WHO Fracture Risk Assessment Tool"
Der informierte Arzt 2013;1:13-17

Kraenzlin M.E.
Recommandations de l’Association Suisse contre l'ostéoporose pour la prise en charge des patients avec ostéoporose.
Rev Med Suisse 2013;9:1272-1278

Meier C., Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter
In: Käftig altern – Die Bedeutung der Kraft im demographischen Wandel. Ed: Menzi et al. 2013

Meier C., Kraenzlin C., Friedrich N.F., Wischer T., Grize L., Meier C.R., Kraenzlin M.E.
Effect of ibandronate for the treatment of osteonecrosis of the knee: A randomized, double-blind, placebo-controlled trial
Osteoporos Int. 2013;epub

Meier C., Kraenzlin M.
Osteoporose: Therapie-Update 2013 (Teil 1): Therapieindikationen und praktisches Vorgehen
Swiss Med Forum 2013;13:811-813

Meier C., Kraenzlin M.
Osteoporose: Therapie-Update 2013 (Teil 2): Medikamente heute und morgen
Swiss Med Forum 2013;13:835-840

Meier C., Kraenzlin M.
The influence of gonadal hormones on skeletal health in men
Osteologie; in print

Meyer U, Ernst D, Zahner L, Schindler C, Puder JJ, Kraenzlin M, Rizzoli R, Kriemler S.
3-year follow-up results of bone mineral content and density after a school-based physical activity randomized intervention trial.
Bone 2013;55:16-22

Sieber P., Lardelli P., Kraenzlin C.A., Kraenzlin M.E. und Meier C.
Intravenous Bisphosphonates for Postmenopausal Osteoporosis: Safety Profiles of Zoledronic Acid and Ibandronate in Clinical Practice
Clin Drug Invest 2013;33:117-122

Stute P., Lippuner K., Birkhäuser M., von Wolff M., Meier C.
Gynecologists’ opinion on bone health care in Switzerland
Swiss Med Wkly 2013; in print

Stute P., Meier C., Schiessl K., Birkhäuser M.
Erläuterungen zur Flow-Chart Diagnose der Osteoporose
Gyn Endokrinol. 2013;23:19-22

Suter-Widmer I., Meier C.
Primärer Hyperparathyroidismus
Leading Opinions Innere Medizin 2013;1:40-42

Suter-Widmer I, Meier C.
Wissenswertes zum Thema Osteoporose in der Zahnarztpraxis
Prämolar 2013;3:16-17

Suter-Widmer I., Meier C.
Bedeutung von Dysfunktionen der Nebenschilddrüse in der späteren Postmenopause
Gynäkologische Endokrinologie 2013;11:272-276

Aeschlimann A. und Kraenzlin M.E.
Schmerzen bei Erkrankungen des Knochens.
In: E. Battegay Ed. Siegenthaler's Differentialdiagnose innerer Kranheiten. 20. Auflage 2012;s378-405

Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R.
Use of metformin is not associated with a decreased risk of colorectal cancer
Cancer Epidemiol Biomarkers Prev 2012; 21: 280-286

Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R.
Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis
Am J Gastroenterol 2012; 107: 620-626
Hadji P., Birkhäuser M., De Geyter C., Finkenstedt G., Hofbauer L., Imthurn B., Meier C., Scharla S., Stute P., Ziller V.
Osteoporose: Phasengerechte Therapie & Neues aus der Zellbiologie
Journal für Mineralstoffwechsel 2012;15:3-7

Meier C., Kraenzlin M.E.
Diagnostik und Verlaufskontrolle der Osteoporose
Therapeutische Umschau 2012;69,3: 145-152

Meier C.
Bedeutung der Präanalytik für die Knochenstoffwechseluntersuchung
Pipette 2012; 4: 17

Meier C.
Antiepileptika und die Gefahr von Osteoporose
Schweiz Zeitschr Psych Neurologie 2012; in print

Meier C.
Struma. In: Martina B., Battegay E., Tschudi P., (eds), 2nd Ed.
Ambulante Medizin – Evidenz auf einen Blick 2012; 154-156

Starke A, Corsenca A, Kohler T, Knubben J, Kraenzlin M, Uebelhart D, Wüthrich RP, von Rechenberg B, Müller R, Ambühl PM
Correction of Metabolic Acidosis with Potassium Citrate in Renal Transplant Patients and its Effect on Bone Quality.
Clin J Am Soc Nephrol. (2012):epub

Suter-Widmer I., Meier C.
Primärer Hyperparathyroidismus
Leading Opinions Innere Medizin 2012;1:40-42


Bodmer M., Becker C., Meier C., Jick S.S., Meier C.R.
Use of metformin and the risk of ovarian cancer: a case-control analysis
Gynecol Oncol 2011, 123: 200-204

Dimai H.P., Meier C.
Osteoporose des Mannes
Der informierte Arzt (2011), 4: 31-34

Dürsteler-MacFarland K.M., Kowalewski R., Bloch N., Wiesbeck G.A., Kraenzlin M., Stohler R.
Patients on injectable diacetylmorphine maintenance have low bone mass
Drug Alcohol Rev (2011), 30: 577-582

Kraenzlin M.E., Meier C.
Parathyroid hormone analogues in the treatment of osteoporosis.
Nature Rev Endocrinol. 2011;7:647-656

Kraenzlin M.E., Meier C.,
Schlaglichter 2010: Neue Wege in der Diagnostik und Therapie der Osteoporose
Swiss Med Forum (2011), 11: 25-28

Kraenzlin M.E., Meier C.
Schlaglichter 2010: Neue Wege in der Diagnostik und Therapie der Osteoporose. Replik
Swiss Med Forum (2011), 11: 325

Kraenzlin M.E., Suter-Widmer I., Meier C.
Sekundäre Osteoporosen
Der informierte Arzt (2011), 4: 26-31

Kraenzlin M.E., Meier C.
Kalzium-Metabolismus: Einige physiologische Bemerkungen
Spectrum Osteoporose (2011), 2: 8-10

Lamy O., Kraenzlin M.
Osteoporosis: evaluation and fracture risk
Rev Med Suisse (2011), 7: 1018-1019

Meier C., Kraenzlin M.E.
Antiepileptics and bone health
Ther Adv Musculoskelet Dis (2011), 3: 235-243

Meier C., Kraenzlin M.E.
Calcium supplementation, osteoporosis and cardiovascular disease
Swiss Med Wkly (2011), 141: w13260

Meier C., Kraenzlin M.E.
Epilepsie, Antiepileptika und Osteoporose       
Epileptologie (2011), 28: 42-50

Meier C., Kraenzlin M.E.
Kathepsin K-Inhibitoren in der Osteoporosetherapie
Osteologie (2011), 20: 211-216

Meyer U., Romann M., Zahner L., Schindler C., Puder J.J., Kraenzlin M., Rizzoli R., Krienler S.
Effect of a general school-based physical activity intervention on bone mineral content and density: a cluster-randomized controlled trial
Bone (2011), 48: 792-797

Rizzoli R., Kraenzlin M., Krieg M.A., Mellinghoff H.U., Lamy O., Lippuner K.
Indications to teriparatide treatment in patients with osteoporosis
Swiss Med Wkly (2011), 141: w13297

Rizzoli R., Lippuner K., Kraenzlin M., Birkhäuser M.
Osteoporosis in Switzerland in 2011: change since 2008
Rev Med Suisse (2011), 7: 1291-1292

Rohrbach M., Vandersteen A., Yis U., Serdaroglu G., Ataman E., Chopra M., Garcia S., Jones K., Kariminejad A., Kraenzlin M., Marcelis C., Baumgartner M., Giunta C.
Phenotypic variability of the kyphoscoliotic type of Ehlers-Danlos syndrome (EDS VIA): clinical, molecular and biochemical delineation
Orphanet J Rare Dis (2011), 6: 46

Suter-Widmer I., Kraenzlin M.E., Meier C.
Primärer Hyperparathyroidismus
Therapeutische Umschau (2011), 68: 321-326

Bischof M., Kraenzlin M., Bucher H., Sendi P.
Cost-Effectiveness of Risedronate Treatment for Preventing Osteoporotic Fractures in Swiss Postmenopausal Women.
Open Pharmaco-econom.&Health Econom. J. (2010), 2:25-33

Bodmer M., Meier C., Krähenbühl S., Jick S.S., Meier C.R.
Long-term metformin use is associated with decreased risk of breast cancer
Diabetes Care (2010), 33: 1304-1308

Bodmer M., Meier C., Kraenzlin M.E., Meier C.R
Proton pump inhibitors and fracture risk: True Effect or Residual Confounding?
Drug Safety (2010), 33: 843-852

Christ E., Giusti V., Meier C., Meier C.A., Pralong F.
Hormonal and nutritional treatments in anti-ageing medicine: A position statement from the Swiss Society for Endocri-nology and Diabetes
Schweiz Med Forum (2010), 10: 271

Cremers S., Meier C., Seibel M.J.
Markers of bone remodelling and the aging skeleton. In: Orwoll E., Bilezikian J., Vanderschueren D (eds), Osteoporosis in men, 2nd ed. Academic Press, San Diego (2010), 423-434

Dürsteler K, Kowalewski R, Bloch N, Wiesbeck G, Kraenzlin M, Stohler R.
Patients on injectable diacetylmorphine maintenance have low bone mass.
Drug Alcohol Rev 2010; publ. online

Keel C., Kraenzlin C.A., Müller B., Kraenzlin M.E., Meier C.
Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practice
J Bone Miner Metab (2010), 28: 68-76

Kraenzlin M.E., Graf C., Meier C., Kraenzlin C.A., Friederich N.F.
Beneficial effect of bisphosphonates in osteonecrosis of the knee
Knee Surg Sports Traumatol Arthrosc (2010), 18: 1638-1644

Kraenzlin M.E., Meier C.
Diabetes mellitus und Osteoporose
D-Journal (2010), 203: 6-11

Kraenzlin M.E., Meier C.
Osteoporose: Wann lohnt sich eine Knochendichte-Messung wirklich?
Hausarzt Praxis (2010), 4: 10-13

Kraenzlin M.E., Meier C.
Diagnostic fortuit - traitment indispensable?
CME pour le médecin de premiers recours (2010), 5: 9-12

Kraenzlin M.
Frakturrisiko und therapeutische Intervention
Journal für Mineralstoffwechsel (2010), 17 (Suppl 1): 39-41

Maggio AB, Ferrari S, Kraenzlin M, Marchand LM, Schwitzgebel V, Beghetti M et al.
Decreased bone turnover in children and adolescents with well controlled type 1 diabetes.
J Pediatr Endocrinol Metab 2010; 23(7):697-707

Meier C., Brauchli Y.B., Jick S.S., Kraenzlin M.E., Meier C.R.
Use of depot medroxyprogesterone acetate and fracture risk
J Clin Endocrinol Metab (2010), 95: 4909-4916

Meier C., Seibel M.J., Kraenzlin M.E.
Biochemical markers of bone turnover: Clinical aspects
In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2010), 131-155

Meier C., Seibel M.J., Handelsman D.J.
Testicular dysfunction and bone. In: Orwoll E., Bilezikian J., Vanderschueren D (eds), Osteoporosis in men, 2nd ed. Academic Press, San Diego (2010), 179-184

Meier C. , Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter
In: Kräftig altern – Die Bedeutung der Kraft im demographischen Wandel. Ed: Menzi et al. (2010), 47-56

Meier C.
Hormonale Ablationstherapie bei Mann und Frau : Folgen für den Knochen
Journal für Mineralstoffwechsel (2010), 17 (Suppl 1): 21-24

Meier C., Kraenzlin M.E.
Primärer Hyperparathyroidismus: Zufällig bemerkt, zwangsläufig zu behandeln?
Hausarzt Praxis (2010), 9: 7-10

Meier C., Kraenzlin M.E.
Hyperparathyroidie primaire
CME pour le médecin de premiers recours (2010), 5: 9-12

Meyer U, Romann M, Zahner L, Schindler C, Puder JJ, Kraenzlin M et al.
Effect of a general school-based physical activity intervention on bone mineral content and density:
A cluster-randomized controlled trial.
Bone (2010), epub

Rizzoli R., Amman P., Birkhäuser M., Ferrari S., Häuselmann H.J., Kraenzlin M.E., Krieg M.A., Lippuner K., Meier C., Theiler R., Uebelhart D., Wimpfheimer C.
Osteoporose: Von der osteodensitometrischen Diagnose zur Evaluation des absoluten Frakturrisikos
Swiss Med Forum (2010), 10 : 111-113

Seibel M.J., Meier C.
Biochemical markers of bone turnover: Basic biochemistry and variability
In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2010), 97-130

Walter M.A., Meier C., Radimerski T., Kranezlin M.E., Müller-Brand J., deGroot J.W.B., Kema I.P., Müller B.
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancer
Cancer (2010), 116: 31-40
Bodmer M., Meier C., Kraenzlin M.E., Meier C.R
Risk of fractures with glitazones: a critical review of the evidence to date
Drug Safety (2009), 32: 539-547

Bonjour J-P, Kraenzlin ME, Rajzbaum G, Rizzoli R.
Ostéoporose: évaluation du risque fracturaire absolu par le questionnaire OMS-FRAX.
Reprod Hum Horm (2009), 12:46-53

De Geyter C., Steinmann S., Müller B., Kraenzlin M.E., Meier C.
Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxin is similar to that in euthyroid controls
Thyroid (2009), 19: 53-59

Hollaender R, Hartl F, Krieg MA, Tyndall A, Geuckel C, Buitrago-Tellez C, Kraenzlin M.E., et al.
Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: Results of the Basel Osteoporosis Study.
Ann Rheum Dis (2009), 68: 391-396

Meier C., Seibel M.J., Kraenzlin M.E.
Use of bone turnover markers in the real world: Are we ready yet?
J Bone Miner Res (2009), 24: 386-388

Meier C.
Knochenumbaumarker und ihre klinische Anwendung bei Osteoporose
Osteologie (2009), 18: 10-15

Meier C.
Osteoporose : Abklärung und medikamentöse Behandlung
Physioactive (2009), 4 : 8-12

Meier C., Bodmer M., Meier C.R., Kraenzlin M.E.
Thiazolidinediones and skeletal health
Rev Med Suisse (2009), 10: 1309-1313

Meier C.
Osteoporose: Diagnostische Aspekte und Frakturrisikoevaluation
Praxis (2009), 98: 1141-1147

Richert L., Trombetti A., Herrmann F., Triponez F., Meier C., Robert J.H., Rizzoli R.
Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in an European country with a particularly high life expectancy
Swiss Med Wkly (2009), 139: 400-404

Rizzoli R., Amman P., Birkhäuser M., Ferrari S., Häuselmann H.J., Kraenzlin M.E., Krieg M.A., Lippuner K., Meier C., Theiler R., Uebelhart D., Wimpfheimer C.
Osteoporose: Du diagnostic osteodensitometrique a l’evaluation du risque absolu de fracture
Swiss Med Forum (2009), 9 : 633-635
De Geyter C., Steinmann S., Müller B., Kraenzlin M.E., Meier C.
Pattern of thyroid function during early pregnancy in women diagnosed with subclinical hypothyroidism and treated with l-thyroxin is similar to that in euthyroid controls
Thyroid (2008), 18: 1-7

Giunta C., Elçioglu N.H., Albrecht B., Eich G., Chambaz C., Janecke A.R., Yeowell H., Weis M.A., Eyre D., Kraenzlin M.E., Steinmann B.
Spondylocheiro dysplastic form of the Ehlers-Danlos syndrome - an autosomal recessive entity caused by mutations in the zinc transporter gene SLC39A13.
Am J Hum Gen 2008; in print

Hollaender R., Hartl F., Krieg M.A., Tyndall A., Geuckel C., Buitrago-Tellez C., Manghani M., Kraenzlin M.E., Theiler R., Hans D.
Prospective evaluation of risk of vertebral fractures using quantitative ultrasound measurements and bone mineral density in a population-based sample of postmenopausal women: Results of the Basel Osteoporosis Study.
Ann Rheum Dis. 2008. Epub

Kraenzlin M.E., Kraenzlin C., Meier C., Giunta C., Steinmann B.
Evaluation of an automated HPLC system for measurement of urinary collagen crosslinks: effect of age, menopause and metabolic bone diseases.
Clin Chem (2008), 54: 1546-1553

Kraenzlin M.E., Griesmacher A., Anliker P.
Die Rolle des Labors in der Diagnostik und Verlaufskontrolle der Osteoporose.
Ther Umschau 2008;65:513-518

Kraenzlin M.E., Meier C.
Therapieverlaufskontrolle - Monitoring bei Osteoporose. In:. Fassbender W. und Pfeilschifter J. Ed. Osteoporose Kompakt. Schattauer Verlag, Stuttgart. 2008:187-197

Kraenzlin M.E., Meier C.
Hyperkalzämie und Kalziumintoxikation. In: Schönenberger R.A., Häfeli W.E., Zimmerli W. eds). Internistische Notfallsituationen.
8th ed. Georg Thieme Verlag, Stuttgart & New York (2008), 211-213

Meier C., Kraenzlin M.E.
Aromatasehemmer und Osteoporose
Leading Opinions Gynäkologie (2008), 1: 14-17

Kraenzlin M.E., Meier C.
Prävention der Osteoporose.
Ars Medici 2008;13:581-585

Kraenzlin M.E., Meier C.
Tetanie. In: Schönenberger R.A., Häfeli W.E., Zimmerli W.  eds). Internistische Notfallsituationen. 8th ed. Georg Thi
me Verlag, Stuttgart & (2008), 213-215

Kriemler S., Zahnera L., Puder J., Braun-Fahrländer C., Schindler C., Farpour-Lambert N., Kraenzlin M.E., Rizzoli R.
Weight bearing bones are more sensitive to physical exercise in boys than in girls during pre- and early puberty.
Osteoporos Int. 2008: in print

Meier C., Nguyen T., Handelsman D.J., Schindler C., Kushnir M.M., Rockwood A.L., Meikle A.W., Center J., Eisman J.A., Seibel M.J.
Endogenous sex hormones and incident fracture risk in older men: The Dubbo Osteoporosis Epidemiology Study.
Arch Intern Med 2008;168: 47-54

Meier C., Kraenzlin M.E., Bodmer M., Jick S.S., Jick H., Meier C.R.
Use of thiazolidinediones and fracture risk
Arch Intern Med 2008;168:820-825

Meier C. , Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter
In: Kräftig altern – Die Bedeutung der Kraft im demographischen Wandel. Ed: Menzi et al. 2008, in print

Meier C., Seibel M.J., Kraenzlin M.E.
Biochemical markers of bone turnover: Clinical aspects
In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. 2008, in print

Meier C., Müller B.
Endokrinologie. In: Schönenberger R.A., Häfeli W.E., Zimmerli W. eds). Internistische Notfallsituationen. 8th ed.
Georg Thieme Verlag, Stuttgart & New York (2008), 494-499

Seibel M.J., Meier C.
Biochemical markers of bone turnover: Basic biochemistry and variability
In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2008), in print

Meier C., Kraenzlin M.E.
Therapieoptionen bei postmenopausaler Osteoporose
Gynäkologie 2008;1: 13-20
Aeschlimann A., Kraenzlin M.E.
Pain and bone disease.
In: W. Siegenthaler Ed. Differentialdiagnosis in Internal Medicine 2007; in print

Denk E., Hillegonds D., Hurrell R., Vogel J., Fattinger K., Häuselmann HJ., Kraenzlin M. and Walczyk T.
Evaluation of 41Calcium as a new approach to assess changes in bone metabolism: effect of a bisphosphonate intervention in postmenopausal women with low bone mass

Kraenzlin M.E.
Biochemical markers in osteoporosis management.
European Muskuloskeletal Disease (2007), in print

Meier C., Kraenzlin M.
Diagnostik und Therapie der Osteoporose: Replik
Schweiz. Med.Forum (2007), in print

Meier C., Kraenzlin M.E.
Gonadal hormones and its influence on skeletal health in men
J Men’s Health and Gender (2007), in print

Meier C. , Kraenzlin M.E.
Krafttraining und Knochengesundheit im Alter
In: Kraeftig altern - Die Bedeutung der Kraft im demographischen Wandel.
Ed: Menzi et al. (2007), in print

Meier C., Seibel M.J.
Knochenumbaumarker und ihre klinische Bedeutung zur Diagnose und Therapiekontrolle von Patienten mit Knochenmetastasen. Teil 2: Prognose und Therapiemonitoring
Schweiz. Zeitschrift für Onkologie (2007), 1:35-38

Meier C., Seibel M.J.
Biochemical markers of bone turnover: Basic biochemistry and variability. In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2007) in print

Meier C., Seibel M.J., Kraenzlin M.E.
Biochemical markers of bone turnover: Clinical aspects. In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2007) in print

Nguyen T., Meier C., Center J., Eisman J. A., Seibel M.J.
Bone turnover in elderly men: Relationships to change in bone mineral density
BMC Musculoskeletal Disorders (2007), 8:13-24

Robertson A., Kraenzlin M.E., Zeilhofer H.F., Meier C.
Bisphosphonat-assoziierte Osteonekrose des Kiefers
Schweiz Med Forum (2007), in print

Seibel M.J., Meier C.
Biochemical markers of bone turnover: Basic biochemistry and variability
In: Osteoporosis: Pathophysiology and Clinical Management, 2nd ed. Ed: Adler R.A. (2007), in print
Guindy J.S., Gysin R., Kraenzlin M.E., Gasser T.C., Hauck K., Meyer J.
Fluoride excretion of adults living in border regions with either water or salt fluoridation.
Schweiz.Monatsschr.Zahnmed. (2006), 116:362-366.

Kraenzlin M.E., Seibel M.J., Meier C.
Diagnostik und Therapie der Osteoporose. 1. Teil
Schweiz Monatsschr. Zahnmed. (2006), 116:1088-1094

Kraenzlin M.E., Meier C.
Osteoporose: Aktuelle Aspekte zu Diagnostik und Therapie. Ihre Bedeutung fuer die Vermeidung von Frakturen bei postmenopausalen Frauen
Ganzheitsmedizin (2006), 18(6):315-320

Kraenzlin M.E., Meier C.
Use of recombinant human TSH in the management of well-differentiated thyroid cancer
Expert Opin Biol Ther (2006), 6: 167-176

Kraenzlin M.E.
Practical use of biochemical markers of bone turnover
Ann Endocrinol (Paris) (2006), 2: 155-157

Kraenzlin M.E., Seibel M.J.
Measurement of bone resorption markers.
In: Seibel M.J., Robins S. P., Bilezikian J. P., eds. Dynamics of bone and cartilage metabolism. 2nd Edition. Chapter 33, p.541-564
Academic Press (2006)

Kraenzlin M.E., Seibel M.J., Meier C.
Diagnostik und Therapie der Osteoporose. 1. Teil
Schweiz Med Forum (2006), 6:712-717

Krieg M.A., Cornuz J., Ruffieux C., Van Melle G., Buche D., Dambacher M. A., Hans D., Hartl F., Hauselmann H. J., Kraenzlin M.E., Lippuner K., Neff M., Pancaldi P., Rizzoli R., Tanzi F., Theiler R., Tyndall A., Wimpfheimer C., Burckhardt P.
Prediction of Hip Fracture Risk by Quantitative Ultrasound in More Than 7000 Swiss Women >/=70 Years of Age: Comparison of Three Technologically Different Bone Ultrasound Devices in the SEMOF Study.
J Bone Miner.Res. (2006), 21:1457-1463

Meier C., Kraenzlin M.E.
Osteoporose und Diabetes mellitus - besteht ein Zusammenhang?
Prisma (2006), 3: 4-7

Meier C., Seibel M.J., Kraenzlin M.E.
Diagnostik und Therapie der Osteoporose. 2. Teil
Schweiz Monatsschr. Zahnmed. (2006), 116:1161-1170

Meier C., Liu P.Y., Seibel M.J., Handelsman D. J.
Sex steroids and skeletal health in men
In: Osteoporosis and Osteoporosis of Rheumatic Diseases. Ed: N.E. Lane and P.N. Sambrook. 1st ed. (2006), p145-156

Meier C.
Struma. In: Martina B., Battegay E., (eds). Ambulante Medizin - Evidenz auf einen Blick (2006), 108-109

Meier C., Seibel M.J., Kraenzlin M.E.
Diagnostik und Therapie der Osteoporose. 2. Teil
Schweiz Med Forum (2006), 6:735-744

Meier C., Meinhardt U., Greenfield J.R., Nguyen T.V., Dunstan C.R., Seibel M.J.
Serum cathepsin K levels reflect osteoclastic activity in women with postmenopausal
osteoporosis and patients with paget’s disease
Clin Lab (2006), 52: 1-10

Meier C., Nguyen T., Seibel M.J.
Monitoring antiresorptive treatment
In: Dynamics of Bone & Cartilage Metabolism. Ed: Seibel M.J., Robins S. P., Bilezikian J. P.
2nd ed., Academic Press, Elsevier Science (2006), 649-669

Meier C.A., Braendle M., Clerici T., Gomez F., Komminoth P., Meier C., Mullis P.E., Portmann L., Pralong F.P., Schmid C., Zumsteg U.W., Fokstuen S.M.D., Antonarakis S.E., Blouin J.L., Braga S., Miny P., Schinzel, Schorderet D.F.
Empfehlungen zur Durchfuhrung von Gentests bei Patienten mit multipler endokriner
Neoplasie (MEN)
Schweiz Med Forum (2006), 6: 299-303

Meier C., Kraenzlin M., Seibel M.J.
Medikamentoese Praevention und Differenzialtherapie der postmenopausalen Osteoporose.
Gynaekolog. Prax. (2006), 30:639-660

Meier C., Kraenzlin M.E.
Subklinische Hypo- und Hyperthyreose. Macht ein Screening auf Schilddrusenfunktionsstoerungen Sinn?
ORL Highlights (2006), 1: 4-8

Meier C., Kraenzlin C., Kraenzlin M.E.
Stellenwert radiologischer Verfahren in der Osteoporosediagnostik
SVMTRA Aktuell (2006), 2: 10-14

Meier C., Kraenzlin M.E.
Diagnostik und Therapie der Osteoporose
Hospitalis (2006), 76: 59-62

Meier C., Seibel M.J.
Knochenumbaumarker und ihre klinische Bedeutung zur Diagnose und Therapiekontrolle von Patienten mit Knochenmetastasen. Teil 1: Diagnostik
Schweiz. Zeitschrift für Onkologie (2006),5:34-39

Moriconi N, Kraenzlin M, Muller B, Keller U, Nusbaumer CP, Stohr S et al.
Body composition and adiponectin serum concentrations in adult patients with cystic fibrosis
J.Clin.Endocrinol.Metab (2006), 91: 1586-90

Nguyen T., Meier C., Seibel M.J.
Variability in the measurement of biochemical markers of bone turnover.
In: Dynamics of Bone & Cartilage Metabolism. Ed: M. J. Seibel, S.P. Robins, J.P. Bilezikian. 2nd ed., Academic Press, Elsevier Science (2006), 565-582

Popp AW, Bodmer C, Senn C, Fuchs G, Kraenzlin ME, Wyss H et al.
Prevention of postmenopausal bone loss with long-cycle hormone replacement therapy
Maturitas (2006); 53: 191-200
Aeschlimann A. und Kraenzlin M.E.
Schmerzen bei Erkrankungen des Knochens.
In: W. Siegenthaler Ed. Differentialdiagnose innerer Kranheiten. 19. Auflage 2005; S 360-381

Blum,C.A., Muller,B., Huber,P., Kraenzlin,M., Schindler,C., De,G.C., Keller,U., and Puder,J.J.
Low-grade inflammation and estimates of insulin resistance during the menstrual cycle in lean and overweight women
J Clin Endocrinol Metab (2005), 90: 3230-3235.

Christ-Crain M., Meier C., Huber P., Zimmerli L., Muller B.
Value of LHRH testing in the differential diagnosis of androgen deficiency in elderly men
J Clin Endocrinol Metab (2005), 90: 1280-1286

Christ-Crain M., Morgenthaler N.G., Muller C., Meier C., Nussbaumer C., Bergmann A., Staub J.J., Muller B.
Pro-A-Type and N-Terminal Pro-B-Type natriuretic peptides in different thyroid function states
Swiss Med Wkly (2005), 135: 549-554

Giunta C, Randolph A, Al-Gazali LI, Brunner HG, Kraenzlin ME, Steinmann B.
Nevo syndrome is allelic to the kyphoscoliotic type of the Ehlers-Danlos syndrome (EDS VIA)
Am J Med Genet A (2005), 133(2): 158-64

Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W.
Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri- and post-menopausal women
Clin Chem Lab Med (2005); 43: 1118-23

Lucas G.J.A., Hocking L.J., Daroszewska A., Cundy T., Nicholson G.C., Walsh J., Fraser W.D, Meier C., Hooper M., Ralston S.H.
UBA domain mutations of SQSTM1 in Paget’s disease of bone: Evidence for a founder effect in patients of British descent
J Bone Miner Res (2005), 20: 227-231

Kraenzlin M.
Nutrition and osteoporosis. When is a supplementation with calcium and vitamin D3 useful?
Ther. Umsch. (2005), 62: 796

Kraenzlin M.
Osteoporose
In: von Planta M, Editor. Evidenzbasierte Innere Medizin.
Koeln: Deutscher Aerzte-Verlag (2005) p. 317-21

Kraenzlin M.
Struma
In: von Planta M, Editor. Evidenzbasierte Innere Medizin.
Koeln: Deutscher Aerzte-Verlag (2005) p. 322-24

Kraenzlin M.
Schilddrusenfunktionsstoerungen
In: von Planta M, Editor. Evidenzbasierte Innere Medizin.
Koeln: Deutscher Aerzte-Verlag (2005) p. 325-29

Kraenzlin M.
Thyreoiditiden
In: von Planta M, Editor. Evidenzbasierte Innere Medizin.
Koeln: Deutscher Aerzte-Verlag (2005) p. 330-32

Meier C., Nguyen T., Center J., Seibel M.J., Eisman J.A.
Bone resorption and osteoporotic fractures in elderly men: The Dubbo Osteoporosis Epidemiology Study
J Bone Miner Res (2005), 20: 579-587

Meier C., Liu P.Y., Handelsman D.J., Seibel M.J.
Endocrine regulation of bone turnover in men
Clin Endocrinol (2005), 63: 603-616

Meier C., Christ-Crain M., Christoffel-Courtin C., Staub J.J., Muller B.
Serum estradiol after single dose hCG administration correlates with Leydig cell reserve in hypogonadal men: Reassessment of the hCG stimulation test
Clin Lab (2005), 51: 509-515

Meier C., Kraenzlin M.E.
Clinical use of teriparatide in the real world
ActaMed (2005), 1: 11

Meier C., Kraenzlin M.E.
Diagnose und Therapie der postmenopausalen Osteoporose
Z Allg Med (2005), 81: 289-302

Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B.
Central fat excess in polycystic ovary syndrome: relation to low-grade inflammation and insulin resistance.
J Clin Endocrinol Metab (2005), 90: 6014-21

Puder J, Kraenzlin M, Keller U.
Diabetes mellitus
In: von Planta M, Editor. Evidenzbasierte Innere Medizin.
Koeln: Deutscher Aerzte-Verlag (2005) p. 311-16.
Christ-Crain M., Meier C., Puder J., Staub J.J., Keller U., Muller B.
Changes of liver function correlate with the improvement of lipid profile after restoration of euthyroidism in patients with subclinical hypothyroidism
Exp Clin Sci Journal (2004), 3: 1-9

Christ-Crain M., Meier C., Huber P., Trummler M., Muller B.
Comparison of different methods for the measurement of serum testosterone in the aging male
Swiss Med Wkly (2004), 134: 193-197

Christ-Crain M., Muller B., Gasser T.C., Kraenzlin M., Trummler M., Huber P., Meier C.
Is there a clinical relevance of partial androgen deficiency of the aging male?
J Urology (2004), 172: 624-627

Christ-Crain M., Meier C., Guglielmetti M., Huber P., Staub J.J., Muller B.
Effect of L-thyroxine replacement therapy on skeletal and cardiac function in subclinical hypothyroidism: A randomized double blind, placebo-controlled trial
The Endocrinologist (2004), 14: 161-166

De Roche R., Rauchfleisch U., Noelpp B., Dittmann V., Ermer A., Stieglitz R.D., Staub J.J., Meier C., Gasser T.C., Luscher N.J.
A team approach to the indication for gender reassignment surgery in transsexuals resulting in long-term outcome improvement
Eur J Plast Surg (2004), 27: 24-28

Meier C., Muller B., Guglielmetti M., Christ-Crain M., Staub J.J., Kraenzlin M.
Restoration of euthyroidism accelerates bone turnover in patients with subclinical hypothyroidism: A rando mized controlled trial
Osteoporos Int (2004), 15: 209-216

Meier C., Liu P., Ly P., de Winter-Modzelewski J., Jimenez M., Handelsman D., Seibel M.J.
Recombinant human chorionic gonadotropin, but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency
J Clin Endocrinol Metab (2004), 89: 3033-3041

Meier C., Woitge H.W., Doschko B., Witte K., Lemmer B, Seibel M.J.
Supplementation with oral vitamin D and calcium during winter prevents seasonal bone loss: A randomized controlled open-label prospective trial
J Bone Miner Res (2004), 19: 1221-1230
Meier C., Muller B., Staub J.J.
Subclinical hypothyroidism. In: Encyclopedia of Endocrinology and Endocrine Diseases.
Ed: L. Martini. Academic Press, Elsevier Science (2004), 737-741

Savoca R, Bock A, Kraenzlin ME et al.
An automated 'bio-intact' PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease.
Clin Chim Acta (2004), 343(1-2): 167-171

Schlienger RG, Kraenzlin ME, Jick SS, Meier CR.
Use of b-blockers and risk of fractures
JAMA (2004), 292: 1326-1332

Seibel M., Meier C., Woitge H.W., Witte K., Lemmer B.
Seasonal variation of bone turnover?
J Bone Miner Res (2004), 19: 168-169

Von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U.
Changes in bone mineral content after surgical treatment of morbid obesity
Metabol (2004), 53: 918-921

Zehnder Y, Luthi M, Michel D, Knecht H, Perrelet R, Neto I, Kraenzlin M, Zach G, Lippuner K.
Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men
Osteoporos Int (2004), 15(3): 180-189
Christ-Crain M., Meier C., Guglielmetti M., Huber P., Riesen W., Staub J.J., Muller B.
Elevated highly sensitive C-reactive protein and homocysteine levels: Cardiovascular risk factors in subclinical and overt hypothyroidism?
Atherosclerosis (2003), 166: 379-386

Christ-Crain M., Meier C., Huber P., Zulewski H., Staub J.J., Muller B.
Effect of restoration of euthyroidism on peripheral blood cells and erythropoietin in women with subclinical hypothyroidism
Hormones (2003), 2: 209-214

De Geyter C., Huber P.R., Decio R., De Geyter M., Meier C.
Role of prolactin during infertility work-up in light of the changing focus of modern reproductive medicine
Reproduktionsmedizin (2003), 19: 9-14

Falconnier Bendik C., Meier C.
Sekundaerer Hyperparathyreoidismus bei Vitamin D-Mangel
Schweiz Rundsch Med Prax (2003), 92: 241-243

Kraenzlin M.E.
Osteomalazie.
Swiss Med Wkly (2003), 32/33: 754-763

Kraenzlin M.E.
Hyperkalzaemie und Kalziumintoxikation
In: Gyr N.E., Schoenenberger R.A., Haefeli W.E. (eds). Internistische Notfallsituationen.
7th ed. Georg Thieme Verlag, Stuttgart & New York (2003), 204-206

Kraenzlin M.E.
Tetanie
In: Gyr N.E., Schoenenberger R.A., Haefeli W.E. (eds). Internistische Notfallsituationen.
7th ed. Georg Thieme Verlag, Stuttgart & New York (2003), 206-207

Meier C., Trittibach P., Guglielmetti M., Kunz M., Staub J.J., Muller B.
Serum TSH is a poor marker for the assessment of the severity of tissue hypothyroidism in patients with severe thyroid failure
BMJ (2003), 326: 311-312

Meier C., Christ-Crain M., Guglielmetti M., Huber P., Staub J.J., Muller B.
Prolactin dysregulation in women with subclinical hypothyroidism: Beneficial effect of L-Thyroxine replacement therapy
Thyroid (2003), 13: 979-985

Meier C., Muller B.
Endokrinologie. In: Gyr N.E., Schoenenberger R.A., Haefeli W.E. (eds). Internistische Notfallsituationen.
7th ed. Georg Thieme Verlag, Stuttgart & New York (2003), 483-488 Mosimann T., Meier C.
Osteomalazie
Schweiz Rundsch Med Prax (2003), 92: 353-355

Staub J.J., Meier C., Christ-Crain M., Muller B.
Ist eine subklinische Hypothyreose behandlungsbedurftig? Klinische und metabolische Veraenderungen vor und nach Therapie
In: Kongressband, 1. Munchner Schilddrusensymposium
Hrsg: Schumm-Draeger / Palitzsch (2003), 5-15

Szinnai G., Meier C., Komminoth P., Zumsteg U.
Prognostic value of codon analysis and therapeutical results of early thyroidectomy in children with Multiple Endocrine Neoplasia type 2A. Report of 4 cases and review of the literature.
Pediatrics (2003), 111: E132-139